Frampton, James E <br/><br/>
Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.  [electronic resource] 

 -  Drugs & aging  May 2013 
 - 331-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1969 
<br/><br/><label>Standard No.: </label>10.1007/s40266-013-0077-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--economics<br/>Choroidal Neovascularization--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Administration Schedule<br/>Europe<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Multicenter Studies as Topic<br/>Randomized Controlled Trials as Topic<br/>Ranibizumab<br/>Treatment Outcome<br/>United States<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors